Abstracts Archive - Page 653 of 1683 - ATC Abstracts

2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Cardiothoracic Transplant Recipients
T. Harrison¹, N. Patel¹, H. Corbo¹, K. Foster¹, H. Meadows¹, N. Pilch¹, C. Perez¹, J. Fleming¹, D. Judge², L. Paoletti³, D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Cardiology, Medical University of South Carolina, Charleston, SC, ³Pulmonary & Critical Care Medicine, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss. It is unclear how medication side effects (SE) and perceived…
2019 American Transplant Congress
Stakeholder Perspectives in Peer Mentoring Program for Pediatric Solid Organ Transplant Recipients
C. Strachan, M. Paton, J. Reason, S. Amaral
Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA
*Purpose: This study analyzed feedback surveys from Peers4PATH, a peer mentoring program, aimed to improve medication adherence and health related quality of life (HRQOL) in…
2019 American Transplant Congress
A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients
J. Langlee, L. Lees, A. Saha, D. Helfer, M. Waldram, A. Love, F. Rivera, A. Massie, D. Segev, D. Brennan, M. Henderson
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The leading predictor of rejection, de novo DSA, graft loss, and death among adult kidney transplant (KT) recipients is immunosuppressive medication nonadherence. An estimated…
2019 American Transplant Congress
Screening for Renal Cell Masses in Kidney Transplant
H. E. Fernandez, D. Tsapepas, D. J. Cohen, M. Sumit, L. E. Ratner
Columbia University MC, New York, NY
*Purpose: End-stage renal disease (ESRD) is a risk factor for development of acquired cystic kidney disease (ACKD) with the incidence of ACKD rising from 90%…
2019 American Transplant Congress
Post-Transplant Cancer Following Living Donor HLA-Incompatible Kidney Transplantation
J. D. Motter¹, K. Jackson¹, S. Bae¹, X. Luo¹, J. Long¹, L. Kucirka¹, B. Orandi², A. Muzaale¹, J. Coresh¹, J. Garonzik-Wang¹, D. Segev¹, A. Massie¹
¹Johns Hopkins University, Baltimore, MD, ²University of Alabama, Birmingham, AL
*Purpose: Incompatible living donor kidney transplantation (ILDKT) recipients require increased immunosuppression compared to their compatible living donor kidney transplant (CLDKT) counterparts. This continued exposure to…
2019 American Transplant Congress
Racial Differences in Cancer Mortality for Kidney Transplant Recipients
K. Cordrey, J. Motter, A. Kernodle, K. Jackson, M. Camp, T. Purnell, D. Segev, J. Garonzik Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Cancer is the second leading cause of post-transplant mortality. Since racial disparities have been reported in many aspects of transplant care, we sought to…
2019 American Transplant Congress
The Impact of Acute Rejection in Heart Transplantation on Post-Transplant Malignancy
K. Kamrani¹, A. Okoh², D. Hanos¹, M. Camacho¹, M. Zucker², K. Clarke¹
¹Dept. of Surgery, Newark Beth Israel Medical Center, Newark, NJ, ²Dept. of Medicine, Newark Beth Israel Medical Center, Newark, NJ
*Purpose: Compared with the general population, an increased incidence of skin cancers and lymphomas have been shown in orthotopic heart transplant (OHT) recipients. However, the…
2019 American Transplant Congress
Post-Transplant Cancer and Graft Failure in Kidney Transplant Recipients
J. Kim, J. Ha, S. Min, H. Lee, Y. Kim, S. Han
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: As the long-term patient survival and graft survival rate are gradually increasing in kidney transplant (KT) recipients, the importance of cancer occurrence and proper…
2019 American Transplant Congress
Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation
W. Lim¹, E. Au², A. Krishnan¹, G. Wong²
¹Sir Charles Gairdner Hospital, Perth, Australia, ²University of Sydney & Westmead Hospital, Sydney, Australia
*Purpose: Incident cancers developing after kidney transplantation are associated with significant morbidity and mortality and therefore age-appropriate cancer screening is recommended to identify asymptomatic cancers…
2019 American Transplant Congress
Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients
B. Clark¹, D. D. Ramirez¹, A. Carlson¹, B. Sirandas¹, C. Truax¹, L. Smith¹, I. Hall²
¹Solid Organ Transplant, University of Utah Health, Salt Lake City, UT, ²Nephrology and Hypertension, University of Utah Health, Salt Lake City, UT
*Purpose: Over half of solid organ transplant recipients (SOTR) develop nonmelanoma skin cancers (NMSC) and up to 80% experience recurrence. Many immunosuppressive drugs are known…